Victims of racism should take Ecstasy or magic mushrooms to reduce the trauma of their experience, suggests a new study.
Exploring the companies and themes that make up this emerging and exciting new sector
Why Canada Could Be Next To Allow Psychedelic Therapy (And How It’s Already Changing Lives)
Canada has an international reputation for progressive health policies, take for example its publicly funded healthcare program and its assisted dying laws. It also led the way in drug reform when it became the first G7 country to legalize cannabis in 2018.
Capital, Compounds and Clinics: Why 2021 Will Be A Stellar Year For Psychedelic Stocks
After a great year in 2020, psychedelic drug stocks are poised for an even better year in 2021.
2020 Was The Year of Psychedelics — Here's Why
While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics.
The Year In Review For Psychedelic Drug Stocks: 2020
2020 was a very good year for the psychedelic drug industry. Psychedelic Stock Watch has compiled our own Report Card on industry performance.
The Best Psychedelic Stocks Can 10x Your Money
Investing in the best psychedelic stocks today could be like getting in on the ground floor of the medical marijuana industry.
Psychedelics Industry Gearing Up For an Even Bigger 2021
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Investments continued flowing into the psychedelic medicine sector this year and will likely continue in 2021 as mental illness cases rise across the globe.
Will Psychedelic Stocks Be The New ESG Favorites For 2021?
Psychedelic drugs have the potential to revolutionize mental health care while simultaneously saving the global economy $100s of billions each year.
UK’s first investment fund dedicated to psychedelic healthcare
In a first for the UK, an investment fund dedicated to psychedelic healthcare has been launched.
How Psychedelic Drug Stocks Took Off in 2020
After some early turbulence in 2020, psychedelic drug stocks have taken off.
Numinus Completes First Extraction of its Psilocybe Mushrooms
VANCOUVER, BC , Dec. 17, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.
Numinus Completes First Extraction of its Psilocybe Mushrooms
Numinus announces the first legal extraction of psilocybe mushrooms in Canada by a public company.